Abbey advises domestic and foreign companies on navigating dynamic trade policies, remaining compliant with U.S. and foreign regulatory requirements, and managing and reducing liabilities in cross-border M&A and investment transactions, agreements, and distribution contracts for foreign sales. She counsels clients on a broad array of trade compliance issues, including import and export controls, economic sanctions on foreign countries (including Iran, Cuba, North Korea, and Russia/Crimea), secondary sanctions on third-country entities, anti-bribery compliance, anti-boycott compliance, Committee on Foreign Investment in the U.S. (CFIUS) and Foreign Investment Risk Review Modernization Act (FIRRMA) reviews and filings, U.S. Customs and Border Protection (CBP) procedures and regulations, USCIS Form I-129 Part 6 Certifications, and sanctions issues pertaining to EB-5 immigration matters.
Abbey works with businesses and entrepreneurs seeking to expand their market position in the global economy. Her experience analyzing, identifying, and leveraging opportunities for doing business worldwide while avoiding the pitfalls associated with global trade has allowed her to guide clients through obstacles in regions around the world. She remains diligently focused on ensuring her clients are in alignment with U.S. trade regulations through the creation of comprehensive compliance programs, including tailored manuals, trainings, and other effective risk management materials. Abbey also performs internal investigations and audits, restricted party and other trade compliance diligence, and trade controls liability assessments. Training program topics include the International Traffic in Arms Regulations (ITAR), the Export Administration Regulations (EAR), the Foreign Corrupt Practices Act (FCPA) and U.K. Bribery Act, and U.S. embargoes and sanctions.
Notably, Abbey delivers honed skill in the aerospace and aviation industry as well as in trade in defense articles and services. She regularly assists clients in trade in technology; trade in health care products and medical devices; country of origin determinations; Bureau of Economic Analysis (BEA) inbound and outbound foreign investment filings; customs seizures; import and export classifications; CBP ruling requests; and obtaining licenses from and navigating the disclosure process under the Department of Commerce's Bureau of Industry and Security (BIS), the Department of State's Directorate of Defense Trade Controls (DDTC), and the Department of the Treasury's Office of Foreign Assets Controls (OFAC).